https://scholars.lib.ntu.edu.tw/handle/123456789/626826
標題: | Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms | 作者: | Sy, Cheng Len PAO-YU CHEN Cheng, Chun-Wen Huang, Ling-Ju Wang, Ching-Hsun Chang, Tu-Hsuan Chang, Yi-Chin Chang, Chia-Jung Hii, Ing-Moi Hsu, Yu-Lung Hu, Ya-Li Hung, Pi-Lien Kuo, Chen-Yen Lin, Pei-Chin Liu, Po-Yen Lo, Ching-Lung Lo, Shih-Hao Ting, Pei-Ju Tseng, Chien-Fang Wang, Hsiao-Wei Yang, Ching-Hsiang Lee, Susan Shin-Jung Chen, Yao-Shen Liu, Yung-Ching Wang, Fu-Der |
關鍵字: | CRAB; CRE; CRPA; Guideline; MDRO; VRE | 公開日期: | 六月-2022 | 出版社: | ELSEVIER TAIWAN | 卷: | 55 | 期: | 3 | 起(迄)頁: | 359 | 來源出版物: | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 摘要: | Antimicrobial drug resistance is one of the major threats to global health. It has made common infections increasingly difficult or impossible to treat, and leads to higher medical costs, prolonged hospital stays and increased mortality. Infection rates due to multidrug-resistant organisms (MDRO) are increasing globally. Active agents against MDRO are limited despite an increased in the availability of novel antibiotics in recent years. This guideline aims to assist clinicians in the management of infections due to MDRO. The 2019 Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group, comprising of infectious disease specialists from 14 medical centers in Taiwan, reviewed current evidences and drafted recommendations for the treatment of infections due to MDRO. A nationwide expert panel reviewed the recommendations during a consensus meeting in Aug 2020, and the guideline was endorsed by the Infectious Diseases Society of Taiwan (IDST). This guideline includes recommendations for selecting antimicrobial therapy for infections caused by carbapenem-resistant Acinetobacter baumannii, carbapenem-resistant Pseudomonas aeruginosa, carbapenem-resistant Enterobacterales, and vancomycin-resistant Enterococcus. The guideline takes into consideration the local epidemiology, and includes antimicrobial agents that may not yet be available in Taiwan. It is intended to serve as a clinical guide and not to supersede the clinical judgment of physicians in the management of individual patients. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/626826 | ISSN: | 1684-1182 | DOI: | 10.1016/j.jmii.2022.02.001 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。